Lipikind is a branded formulation of atorvastatin, a statin (HMG-CoA reductase inhibitor) used to lower cholesterol and reduce cardiovascular risk. It's marketed in different strengths (e.g., Lipikind 10, Lipikind 20).
What it's used for
- High cholesterol and high triglycerides
- Primary and secondary prevention of heart attack and stroke in patients with atherosclerotic cardiovascular disease or risk factors (diabetes, hypertension, smoking, family history)
How it works
Atorvastatin inhibits HMG-CoA reductase, the rate-limiting enzyme in hepatic cholesterol synthesis. This upregulates LDL receptor expression on hepatocytes, increasing clearance of LDL from the blood, and lowers LDL, total cholesterol, and triglycerides while modestly raising HDL - Katzung's Basic and Clinical Pharmacology, 16th Ed.
Dosing
Typically once daily, any time of day, with or without food, commonly starting at 10-20 mg and titrated up to 40-80 mg depending on the LDL target and cardiovascular risk category. Exact dose should be set by the prescribing physician based on lipid panel and risk profile.
Common side effects
- Muscle aches/myalgia (occasionally myopathy or, rarely, rhabdomyolysis)
- Elevated liver enzymes
- Headache, GI upset (nausea, diarrhea, constipation)
- Rare: new-onset diabetes with long-term use
Important interactions
Atorvastatin is metabolized via CYP3A4, so drugs that inhibit this enzyme (certain antivirals/protease inhibitors, azole antifungals, some antiarrhythmics, nefazodone, cobicistat) can raise atorvastatin levels and increase myopathy risk, while CYP3A4 inducers (rifampin, carbamazepine, phenytoin) can reduce its effectiveness - Katzung's Basic and Clinical Pharmacology, 16th Ed. Combining with fibrates (e.g., clofibrate) also raises myopathy risk. Grapefruit juice in large amounts can raise levels too.
Evidence base
Landmark trials support high-intensity atorvastatin (e.g., 80 mg) for aggressive LDL lowering post-acute coronary syndrome; the PROVE IT-TIMI 22 trial showed atorvastatin 80 mg achieved lower LDL (~62 mg/dL) than pravastatin 40 mg and improved outcomes - Fuster and Hurst's The Heart, 15th Ed.
Recent meta-analyses (2024-2026) reinforce and refine this: one comparing rosuvastatin vs. atorvastatin on LDL/TG/HDL changes (PMID 40132725), and another on atorvastatin's anti-inflammatory and pulmonary effects (PMID 41555409) — worth reviewing if you want statin comparison data specifically, but neither contradicts standard safety guidance.
If you can tell me what you specifically want to know (e.g., a particular strength's dosing, side effects you're experiencing, or whether it's safe with another medication you're taking), I can go more specific — statin advice should ultimately be confirmed with your prescribing doctor or pharmacist since dosing depends on your individual lipid levels and risk factors.